Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 350 of 46697 entries
View as:
0.0% Compliant
Total: 12
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 66
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 12
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 24
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| AJU Pharm Co., Ltd. | - | 12 | 0.0% | 0 | 0 | 0.0% | - | AJU Pharm Co., Ltd..temp.org | 2025-07-14 |
| AKARI Therapeutics | - | 8 | 0.0% | 0 | 0 | 0.0% | - | AKARI Therapeutics.temp.org | 2025-07-14 |
| AKI Critical Care Research Foundation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AKI Critical Care Research Foundation.temp.org | 2025-07-14 |
| AKL Research and Development | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AKL Research and Development.temp.org | 2025-07-14 |
| AL Yousef | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AL Yousef.temp.org | 2025-07-14 |
| AL-Nour Eye Hospital | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AL-Nour Eye Hospital.temp.org | 2025-07-14 |
| AL-S Pharma | - | 2 | 0.0% | 0 | 0 | 0.0% | - | AL-S Pharma.temp.org | 2025-07-14 |
| ALDO TORRE DELGADILLO | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALDO TORRE DELGADILLO.temp.org | 2025-07-14 |
| ALDUS Study Group | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALDUS Study Group.temp.org | 2025-07-14 |
| ALESSANDRA CARTA | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALESSANDRA CARTA.temp.org | 2025-07-14 |
| ALI BAHADIRLI | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALI BAHADIRLI.temp.org | 2025-07-14 |
| ALI KAMAL M. SAMI | - | 3 | 0.0% | 0 | 0 | 0.0% | - | ALI KAMAL M. SAMI.temp.org | 2025-07-14 |
| ALK Nordic A/S, Danmark Filial | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALK Nordic A/S, Danmark Filial.temp.org | 2025-07-14 |
| ALK-Abelló A/S | - | 66 | 0.0% | 0 | 0 | 0.0% | - | ALK-Abelló A/S.temp.org | 2025-07-14 |
| ALPFA Medical | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALPFA Medical.temp.org | 2025-07-14 |
| ALPS Biotech CO. LTD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALPS Biotech CO. LTD.temp.org | 2025-07-14 |
| ALS Therapy Development Institute | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALS Therapy Development Institute.temp.org | 2025-07-14 |
| ALTality, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ALTality, Inc..temp.org | 2025-07-14 |
| ALX Oncology Inc. | - | 8 | 0.0% | 0 | 0 | 0.0% | - | ALX Oncology Inc..temp.org | 2025-07-14 |
| ALZA | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALZA.temp.org | 2025-07-14 |
| ALshaimaa Aboalhassan Ali | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ALshaimaa Aboalhassan Ali.temp.org | 2025-07-14 |
| AM-Pharma | - | 12 | 0.0% | 0 | 0 | 0.0% | - | AM-Pharma.temp.org | 2025-07-14 |
| AMAG Pharmaceuticals, Inc. | - | 24 | 0.0% | 0 | 0 | 0.0% | - | AMAG Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| AMCG | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AMCG.temp.org | 2025-07-14 |
| AMES Technology | - | 4 | 0.0% | 0 | 0 | 0.0% | - | AMES Technology.temp.org | 2025-07-14 |